Pressor Effectiveness in Acidosis

Mechanisms and Clinical Evidence

Severe acidosis causes catecholamine receptor resistance, reducing the binding efficacy of vasopressors to their target receptors 1

For severe acidosis (pH <7.1 and bicarbonate <10 mEq/L), intravenous sodium bicarbonate administration is indicated to improve vasopressor efficacy, as recommended by guideline societies such as the American Heart Association 2
The American Heart Association recommends sodium bicarbonate administration for special situations such as severe acidosis with pH <7.15 to overcome catecholamine receptor resistance-induced hypotension 3
In refractory hypoxemia or acidosis where catecholamine vasopressors may be attenuated, vasopressin may be preferred as it works through non-adrenergic mechanisms, according to the American College of Cardiology 1, 4
For patients with shock and severe acidosis, consider using vasopressin as an adjunct or alternative to catecholamine vasopressors, as suggested by the American College of Cardiology 4

In patients with persistent shock despite fluid administration and severe acidosis, consider elective intubation and ventilation to help manage acidosis, as recommended by the British Medical Journal 5
Patients with severe acidosis may self-ventilate their PCO2 to very low levels as compensation; when initiating mechanical ventilation, avoid rapid rise of PCO2 before acidosis has been partly corrected, according to the British Medical Journal 5
For refractory shock with extreme acidosis, consider mechanical circulatory support if conventional therapies fail, as suggested by the American Heart Association 1

Overly rapid correction of acidosis can lead to paradoxical central nervous system acidosis and cerebral edema, as warned by the American College of Medical Toxicology 2
Excessive bicarbonate administration may cause hypernatremia and hyperosmolarity, potentially worsening outcomes, according to the American Heart Association 6
Bicarbonate produces excess CO2, which can diffuse into myocardial and cerebral cells, potentially worsening intracellular acidosis, as noted by the American College of Cardiology 6

The American College of Cardiology recommends vasopressin as the preferred vasopressor in patients with severe acidosis (pH <7.15) because it acts through non-adrenergic mechanisms that are not affected by acidosis 7

In moderate acidosis (pH 7.15-7.30), the American College of Cardiology recommends continuing with norepinefrine as the first-line vasopressor (0.1-1.3 µg/kg/min) and correcting the underlying cause of acidosis (hypoperfusion, sepsis) 8, 9
In severe acidosis (pH <7.15), changing to vasopressin as the preferred vasopressor (0.01-0.04 U/min) is recommended because it maintains effectiveness when catecholaminergic vasopressors are attenuated 7, 8, 9

The American College of Cardiology recommends preferring vasopressin over catecholaminergic vasopressors in patients with refractory hypoxemia or severe acidosis 7
For cardiogenic shock with acidosis, considering norepinephrine or vasopressin to maintain right ventricular perfusion during inodilator therapy with milrinone is recommended 10